Raybould H E, Meyer J H, Tabrizi Y, Liddle R A, Tso P
Center for Ulcer Research and Education/Digestive Diseases Research Center, Department of Physiology, University of California Los Angeles School of Medicine, Los Angeles, CA 90073, USA.
Am J Physiol. 1998 Jun;274(6):R1834-8. doi: 10.1152/ajpregu.1998.274.6.R1834.
Lipid in the intestine initiates feedback inhibition of proximal gastrointestinal function and food intake. In rats and humans, inhibition of gastric emptying is mediated, at least in part, by cholecystokinin (CCK)-A receptors, and in rats there is evidence for involvement of an intestinal vagal afferent pathway. The mechanism by which luminal lipid acts to release CCK or activate vagal afferent nerve terminals is unclear. The role of chylomicron formation in this sensory transduction pathway has been investigated using the hydrophobic surfactant Pluronic L-81 that inhibits chylomicron formation. Gastric emptying of liquids was measured in awake rats fitted with a Thomas gastric fistula and a duodenal cannula. Intestinal perfusion of lipid induced a dose-dependent inhibition of gastric emptying (6, 12, and 39% inhibition for 25, 50, and 100 mg lipid, respectively). Perfusion of lipid with Pluronic L-81 (2.8% wt/vol) reversed the lipid-induced inhibition of gastric emptying. Pluronic L-63, a chemically similar surfactant that has no effect on chylomicron formation, had no effect on lipid-induced inhibition of gastric emptying. Perfusion of the intestine with lipid (100 mg) increased plasma levels of CCK from 1.9 +/- 0.8 to 6. 5 +/- 1 pM. This increase was blocked by Pluronic L-81 but unaffected by L-63. These results provide evidence that chylomicron formation is important in the signaling of lipid in the intestinal lumen to CCK endocrine cells and to producing feedback inhibition of gastric emptying.
肠道中的脂质会引发对近端胃肠功能和食物摄入的反馈抑制。在大鼠和人类中,胃排空的抑制至少部分是由胆囊收缩素(CCK)-A受体介导的,并且在大鼠中有证据表明存在肠道迷走神经传入途径。管腔内脂质释放CCK或激活迷走神经传入神经末梢的机制尚不清楚。已使用抑制乳糜微粒形成的疏水性表面活性剂普朗尼克L-81研究了乳糜微粒形成在该感觉转导途径中的作用。在装有托马斯胃瘘管和十二指肠插管的清醒大鼠中测量液体的胃排空。肠道灌注脂质会引起剂量依赖性的胃排空抑制(分别对25、50和100mg脂质有6%、12%和39%的抑制)。用普朗尼克L-81(2.8%重量/体积)灌注脂质可逆转脂质诱导的胃排空抑制。普朗尼克L-63是一种化学性质相似但对乳糜微粒形成无影响的表面活性剂,对脂质诱导的胃排空抑制没有作用。用脂质(100mg)灌注肠道会使CCK的血浆水平从1.9±0.8升高至6.5±1pM。这种升高被普朗尼克L-81阻断,但不受L-63影响。这些结果提供了证据,表明乳糜微粒的形成在管腔内脂质向CCK内分泌细胞的信号传导以及产生对胃排空的反馈抑制中很重要。